Position in OGN
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$85,854
-$237,052 QoQ
Shares Held
14,333
+4.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MML INVESTORS SERVICES, LLC holds $792,094,279 across 15 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
176,497 | $211,695,814 | |
| 2 | ABBV |
AbbVie Inc.
|
632,277 | $159,106,184 | |
| 3 | JNJ |
Johnson & Johnson
|
408,511 | $103,749,538 | |
| 4 | AMGN |
Amgen Inc
|
212,074 | $76,796,236 | |
| 5 | MRK |
Merck & Co., Inc.
|
444,129 | $57,070,576 | |
| 6 | NVS |
Novartis AG
|
255,770 | $40,084,274 | |
| 7 | PFE |
Pfizer Inc
|
1,393,942 | $33,566,123 | |
| 8 | AZN |
Astrazeneca PLC
|
171,254 | $32,473,183 |
All Filings in OGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $85,854 | 14,333 | Shares | Defined | 2026-05-04 | |
| 2023-03-31 | $322,906 | 13,729 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $631,301 | 22,603 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $582,309 | 24,885 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $636,896 | 18,871 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $640,720 | 18,343 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $526,206 | 17,281 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $632,256 | 19,282 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $357,612 | 11,818 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||